Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis.
Salhotra VS, Sachdeva KS, Kshirsagar N, Parmar M, Ramachandran R, Padmapriyadarsini C, Patel Y, Mehandru L, Jaju J, Ponnuraja C, Gupta M, Kalaiselvan V, Shamim A, Khaparde S, Swaminathan S; Bedaquiline CAP Site Teams.
Salhotra VS, et al. Among authors: ponnuraja c.
Indian J Tuberc. 2020 Jan;67(1):29-37. doi: 10.1016/j.ijtb.2019.10.002. Epub 2019 Oct 16.
Indian J Tuberc. 2020.
PMID: 32192613